BioSpace News Archive

This partnership will significantly widen Trialbee’s service offerings to drive patient recruitment and retention

Exagen Inc., an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention, announced the publication of two key studies.

First AI Product Cleared for MRI Image Enhancement

Funding will help ColdQuanta advance its Quantum Core™ technology platform, leading to quantum signal processing systems, quantum positioning systems, and quantum computers

Concern for environmental impact results in 80% reduction of waste in packaging

Company Also Expands Sales Team to Include Five Leaders with Extensive Neurovascular Experience

When the three-year expansion is totally complete, Health Wright Products will have the capability to produce over five billion capsules per year up from 1.8 billion capsules currently.

The Critical Path Institute and CDISC are pleased to announce the release of a global Foundational Standard that describes how to represent data for the natural history and efficacy studies conducted in animals submitted to applications under the U.S. Food and Drug Administration regulations commonly known as the Animal Rule.

Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, announced that it has earned The Joint Commission’s Surgical Ambulatory Health Care Accreditation by demonstrating continuous compliance with its performance standards.

Harborside Inc. (“Harborside” or the “Company”) (CSE: HBOR), a California-focused, vertically integrated cannabis enterprise, announced today that key executives, members of the Board of Directors and insiders, have entered into an additional, extended voluntary lock-up agreement with the Company,